Perinatal Mortality Trend Associated with Maternal Obesity in United States between 2015 and 2020

Abstract

Objective Obesity is associated with an increased risk of stillbirth and neonatal death. Since the publication of A Randomized Trial of Induction Versus Expectant Management (ARRIVE) in 2018, there was an increase in 39-week deliveries. The objective of this study was to evaluate the trends in perinatal mortality by body mass index (BMI) category from 2015 to 2020.

Study Design This was a retrospective cohort study of U.S. births between 2015 and 2020. The rates of stillbirths, infant deaths, and perinatal mortality were calculated for each BMI category. Logistic regression models were constructed based on specific outcome rates from 2015 to 2018 to predict the rates in 2019 and 2020. The predicted rates were compared with the actual rates to determine possible deviations due to policy and practice changes that occurred.

Results Between 2015 and 2018, the stillbirth rate increased for ascending BMI categories. Whereas the neonatal death rate decreased for all except the underweight group, the perinatal death rate increased in all except for those with category III obesity. In 2019 the perinatal mortality rate decreased for every BMI category except underweight group. In 2020, the rate of infant deaths increased for all BMI categories compared with the predicted rates. The results were similar after excluding common comorbidities.

Conclusion Perinatal mortality rates improved in 2019, reversing the increasing trend from 2015 to 2018. However, this trend did not persist for some BMI categories in 2020. These findings may suggest a beneficial effect of policy changes since the ARRIVE trial publication and the negative effects from the coronavirus disease 2019 pandemic.

Key Points

• There was a trend toward decreasing perinatal mortality in 2019 compared with previous years.

• The downward trend in perinatal mortality may be attributed to an increase in 39-week deliveries.

• The downward trend in perinatal mortality did not persist into 2020, likely due to COVID-19.

Keywords

obesity - perinatal mortality - stillbirth

Note

Poster presentation of this study was at the 2023 Society of Maternal Fetal Medicine Pregnancy Meeting, San Francisco, CA, February 6 to 11, 2023.

Publication History

Received: 15 October 2024

Accepted: 08 January 2025

Accepted Manuscript online:
09 January 2025

Article published online:
31 January 2025

• References

• 1 Adult Obesity Facts. Center for Disease Control and Prevention. May 22, 2022. Accessed April 3, 2024 at: https://www.cdc.gov/obesity/data/adult.html
• 2 Stierman B, Afful J, Carroll MD. et al. National health and nutrition examination survey 2017–March 2020 prepandemic data files-development of files and prevalence estimates for selected health outcomes. Natl Health Stat Rep 2021; 2021 (158)
• 3 Driscoll AK, Gregory ECW. Increases in prepregnancy obesity: United States, 2016-2019. NCHS Data Brief 2020; (392) 1-8
• 4 Chu SY, Kim SY, Lau J. et al. Maternal obesity and risk of stillbirth: a metaanalysis. Am J Obstet Gynecol 2007; 197 (03) 223-228
• 5 Nohr EA, Bech BH, Davies MJ, Frydenberg M, Henriksen TB, Olsen J. Prepregnancy obesity and fetal death: a study within the Danish National Birth Cohort. Obstet Gynecol 2005; 106 (02) 250-259
• 6 Yao R, Ananth CV, Park BY, Pereira L, Plante LA. Perinatal Research Consortium. Obesity and the risk of stillbirth: a population-based cohort study. Am J Obstet Gynecol 2014; 210 (05) 457.e1-457.e9
• 7 Yao R, Schuh BL, Caughey AB. The risk of perinatal mortality with each week of expectant management in obese pregnancies. J Matern Fetal Neonatal Med 2019; 32 (03) 434-441
• 8 Grobman WA, Rice MM, Reddy UM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Labor induction versus expectant management in low-risk nulliparous women. N Engl J Med 2018; 379 (06) 513-523
• 9 Society of Maternal-Fetal (SMFM) Publications Committee. Electronic address: [e-mail]. SMFM statement on elective induction of labor in low-risk nulliparous women at term: the ARRIVE trial. Am J Obstet Gynecol 2019; 221 (01) B2-B4
• 10 Committee on Obstetric Practice, Committee on Practice Bulletins—Obstetrics. Clinical Guidance for Integration of the Findings of The ARRIVE Trial: labor induction versus expectant management in low-risk nulliparous women. American College of Obstetricians and Gynecologists;
• 11 Souter V, Nethery E, Levy B, Mclean K, Sitcov K. Elective induction of labor in nulliparas: has the ARRIVE trial changed obstetric practices and outcomes?. Am J Obstet Gynecol 2022;226(01):
• 12 Nethery E, Levy B, McLean K, Sitcov K, Souter VL. Effects of the ARRIVE (A Randomized Trial of Induction Versus Expectant Management) Trial on elective induction and obstetric outcomes in term nulliparous patients. Obstet Gynecol 2023; 142 (02) 242-250
• 13 American College of Obstetricians and Gynecologists, Society of Maternal Fetal Medicine. Leaders in Obstetric Care Respond to the Published Results of the ARRIVE Trial. American College of Obstetricians and Gynecologists;
• 14 Itriyeva K. The effects of obesity on the menstrual cycle. Curr Probl Pediatr Adolesc Health Care 2022; 52 (08) 101241
• 15 Fitzsimons KJ, Modder J, Greer IA. Obesity in pregnancy: risks and management. Obstet Med 2009; 2 (02) 52-62
• 16 NVSS - Linked Birth and Infant Death Data. Accessed September 15, 2024 at: https://www.cdc.gov/nchs/nvss/linked-birth.htm
• 17 Crane JMG, Murphy P, Burrage L, Hutchens D. Maternal and perinatal outcomes of extreme obesity in pregnancy. J Obstet Gynaecol Can 2013; 35 (07) 606-611
• 18 Hao YJ, Wang YL, Wang MY. et al. The origins of COVID-19 pandemic: a brief overview. Transbound Emerg Dis 2022; 69 (06) 3181-3197
• 19 Sobolewska-Pilarczyk M, Pokorska-Śpiewak M, Stachowiak A. et al. COVID-19 infections in infants. Sci Rep 2022; 12 (01) 7765